Retatrutide 20mg
Retatrutide is a synthetic peptide described in research as a triple agonist, targeting the GLP-1, GIP and glucagon receptors. It is a relatively new, widely studied compound within metabolic research.
Research context
Retatrutide is investigated in relation to the simultaneous activation of three receptor pathways involved in energy and glucose metabolism. It is a study compound within our GLP-1 / metabolic line and intended for research use only.
Specifications
- Compound: Retatrutide
- Contents: 20 mg per vial
- Form: lyophilised white powder
- Purity: >99% (HPLC verified)
- Includes: 3ml BAC water and 4 injection needles supplied free with every order
Storage & reconstitution
Store lyophilised, cool and dark; long-term at −20 °C. After reconstitution, store refrigerated and use within the usual research timeframe. Determine the volume with our calculator.
Quality
Independently tested per batch; the Certificate of Analysis (COA) is available on our COA page.
Disclaimer
For laboratory and research use only. Not for human or animal consumption.
Beoordelingen
Er zijn nog geen beoordelingen.